‘From the Bench to Bedside and Back’ is focal point for this year’s conference
When it comes to questions about the need for laser in diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR), the answers are “yes” and “no,” depending on the clinical scenario, said John Wells, MD.
Anti-vascular endothelial growth factor (VEGF) therapy is a viable alternative to panretinal photocoagulation (PRP) in eyes with proliferative diabetic retinopathy (PDR).
Though anterior uveitis is associated with myriad conditions, a relatively short list of disorders accounts for the vast majority of cases.
Group of researchers aim to validate both approaches in proof-of-concept study
Inhibition plays role in autoimmune-based inflammation; has unique mechanism of action
Improvement in visual acuity, central retinal thickness, vitreous haze reported at 6 months
FA implant effective in lowering recurrence rates through available 6, 12 months of follow-up
Quiescence, steroid-free quiescence achieved in VISUAL III trial